NewAmsterdam Pharma begins Phase 2b trial of obicetrapib in Alzheimer's
Tweet Send to a Friend
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) announced the dosing of the first participant in SPINOZA, a Phase 2b clinical trial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
